Høhloch, Karin

[["dc.bibliographiccitation.firstpage","1031"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Annals of Hematology"],["dc.bibliographiccitation.lastpage","1038"],["dc.bibliographiccitation.volume","100"],["dc.contributor.author","Zettl, Florian"],["dc.contributor.author","Ziepert, Marita"],["dc.contributor.author","Altmann, Bettina"],["dc.contributor.author","Zeynalova, Samira"],["dc.contributor.author","Held, Gerhard"],["dc.contributor.author","Pöschel, Viola"],["dc.contributor.author","Hohloch, Karin"],["dc.contributor.author","Wulf, Gerald G."],["dc.contributor.author","Glass, Bertram"],["dc.contributor.author","Schmitz, Norbert"],["dc.contributor.author","Loeffler, Markus"],["dc.contributor.author","Trümper, Lorenz"],["dc.date.accessioned","2021-04-14T08:30:49Z"],["dc.date.available","2021-04-14T08:30:49Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1007/s00277-020-04345-3"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/83385"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1432-0584"],["dc.relation.issn","0939-5555"],["dc.title","Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","23"],["dc.bibliographiccitation.journal","Blood"],["dc.bibliographiccitation.volume","126"],["dc.contributor.author","Hohloch, Karin"],["dc.contributor.author","Altmann, Bettina"],["dc.contributor.author","Pfreundschuh, Michael"],["dc.contributor.author","Loeffler, Markus"],["dc.contributor.author","Schmitz, Norbert"],["dc.contributor.author","Ziepert, Marita"],["dc.contributor.author","Truemper, Lorenz H."],["dc.date.accessioned","2018-11-07T09:47:41Z"],["dc.date.available","2018-11-07T09:47:41Z"],["dc.date.issued","2015"],["dc.identifier.isi","000368019004309"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/35161"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Amer Soc Hematology"],["dc.publisher.place","Washington"],["dc.relation.conference","57th Annual Meeting of the American-Society-of-Hematology"],["dc.relation.eventlocation","Orlando, FL"],["dc.relation.issn","1528-0020"],["dc.relation.issn","0006-4971"],["dc.title","Obesity Is a Prognostic Factor in Elderly Female Patients with Aggressive B-Cell Lymphomas Treated with R-CHOP"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","7539"],["dc.bibliographiccitation.issue","15_suppl"],["dc.bibliographiccitation.journal","Journal of Clinical Oncology"],["dc.bibliographiccitation.lastpage","7539"],["dc.bibliographiccitation.volume","34"],["dc.contributor.author","Zettl, Florian"],["dc.contributor.author","Ziepert, Marita"],["dc.contributor.author","Altmann, Bettina"],["dc.contributor.author","Zeynalova, Samira"],["dc.contributor.author","Loeffler, Markus"],["dc.contributor.author","Schmitz, Norbert"],["dc.contributor.author","Pfreundschuh, Michael"],["dc.contributor.author","Hohloch, Karin"],["dc.contributor.author","Trümper, Lorenz"],["dc.date.accessioned","2020-12-10T18:41:30Z"],["dc.date.available","2020-12-10T18:41:30Z"],["dc.date.issued","2016"],["dc.identifier.doi","10.1200/JCO.2016.34.15_suppl.7539"],["dc.identifier.eissn","1527-7755"],["dc.identifier.issn","0732-183X"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77599"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Age-dependent analysis of toxicity, mortality, and implementation of an anti-infective prophylaxis in 1171 elderly patients (pts) with aggressive B-cell lymphoma (aNHL): Data from consecutive phase II and III trials of the DSHNHL."],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]